Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 6 signals
Share change
+197,297
SEC-reported price per share
$17.35
Number of holders
30
Value change
+$4,174,540
Number of buys
22
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
71,530,793

Security key

92337R101

Report period

Q3 2021

Institutions

30

Top holders

10

Ownership snapshot

Top reported holders of VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Abingworth LLP
Disclosed value leader
Emster Kurt von
Comparable rows
0/15
Latest evidence
30 Jun 2021
3/4/5 13F Highest disclosed value: $53,605,062 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Emster Kurt von has the largest disclosed position value at $53.61M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Emster Kurt von's linked filing trail.
Disclosed position value Top 5
Abingworth LLP $53.28M
Emster Kurt von $53.61M
Sofinnova Investments, Inc. $38.65M
FMR LLC $38.48M
CITADEL ADVISORS LLC $22.17M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Abingworth LLP
3/4/5 13F
10%+ Owner · Company
—
mixed-class rows
$53,284,158
2,970,156 shares
mixed-class rows
— 13 May 2021
Emster Kurt von
3/4/5
Director
—
mixed-class rows
$53,605,062
2,987,984 shares
mixed-class rows
— 17 May 2021
Sofinnova Investments, Inc.
13F
Company
13F
—
denominator unverified
$38,650,000
2,914,776 shares
— 30 Jun 2021
FMR LLC
13F
Company
13F
—
denominator unverified
$38,475,000
3,122,512 shares
— 30 Jun 2021
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$22,170,000
1,738,693 shares
— 30 Jun 2021
KPCB XVI Associates, LLC
13F
Company
13F
—
denominator unverified
$16,029,000
1,343,152 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
14,710,587
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
21
Q3 2021 holders
30
Holder diff
9
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .